Re: Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease

被引：1
作者：
Masterson, Thomas [1 ]
Patel, Premal [1 ]
Ramasamy, Ranjith [1 ]
机构：
[1] Univ Miami, Miami, FL 33136 USA
来源：
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH | 2020年 / 32卷 / 02期
关键词：
D O I：
10.1038/s41443-019-0127-x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：251 / 252
页数：2
相关论文
共 6 条
  • [1] Predictors of treatment success after collagenase Clostridium histolyticum injection for Peyronie's disease: development of a nomogram from a multicentre single-arm, non-placebo controlled clinical study
    Cocci, Andrea
    Russo, Giorgio Ivan
    Briganti, Alberto
    Salonia, Andrea
    Cacciamani, Giovanni
    Capece, Marco
    Falcone, Marco
    Timpano, Massimiliano
    Cito, Gianmartin
    Verze, Paolo
    Giammusso, Bruno
    Morgia, Giuseppe
    Mirone, Vincenzo
    Minervini, Andrea
    Gacci, Mauro
    Cai, Tommaso
    Serni, Sergio
    Carini, Marco
    Giubilei, Gianluca
    Mondaini, Nicola
    [J]. BJU INTERNATIONAL, 2018, 122 (04) : 680 - 687
  • [2] Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies
    Gelbard, Martin
    Goldstein, Irwin
    Hellstrom, Wayne J. G.
    McMahon, Chris G.
    Smith, Ted
    Tursi, James
    Jones, Nigel
    Kaufman, Gregory J.
    Carson, Culley C.
    [J]. JOURNAL OF UROLOGY, 2013, 190 (01) : 199 - 207
  • [3] Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies
    Lipshultz, Larry I.
    Goldstein, Irwin
    Seftel, Allen D.
    Kaufman, Gregory J.
    Smith, Ted M.
    Tursi, James P.
    Burnett, Arthur L.
    [J]. BJU INTERNATIONAL, 2015, 116 (04) : 650 - 656
  • [4] Limited success with clostridium collagenase histolyticum following FDA approval for the treatment of Peyronie's disease
    Tsambarlis, Peter N.
    Yong, Raymond
    Levine, Laurence A.
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2019, 31 (01) : 15 - 19
  • [5] Contemporary surgical and non-surgical management of Peyronie's disease
    Wayne, George F.
    Cordon, Billy H.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (04) : 603 - 617
  • [6] Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men With Peyronie's Disease
    Wymer, Kevin
    Ziegelmann, Matthew
    Savage, Joshua
    Kohler, Tobias
    Trost, Landon
    [J]. UROLOGY, 2018, 119 : 109 - 114
1